Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer

BACKGROUND: The EGFR signaling pathway is frequently activated in human ovarian cancer and associated with poor prognosis. However, inhibition of EGFR signaling in patients with recurrent ovarian cancer has been disappointing. It remains to be addressed whether ovarian cancer patients could benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Wei, Wu, Jun, Liu, Lucy, Tian, Yan, Buettner, Ralf, Hsieh, Meng-Yin, Horne, David, Dellinger, Thanh H, Han, Ernest S, Jove, Richard, Yim, John H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437681/
https://www.ncbi.nlm.nih.gov/pubmed/25928246
http://dx.doi.org/10.1186/s12943-015-0366-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437681/
https://www.ncbi.nlm.nih.gov/pubmed/25928246
http://dx.doi.org/10.1186/s12943-015-0366-5

Ejemplares similares